Tag: LDL Cholesterol Reduction

Verve 102 is an experimental treatment designed to lower levels of low-density lipoprotein (LDL) cholesterol by targeting the PCSK9 gene in liver cells. This approach departs from traditional long-term medication regimens, as it aims to offer...